Federation Assumes a Federation
A breakthrough proved the science works. The next chapter is making it sustainable.
Blog
Product insights, company updates, and perspectives from the Loopora team.
LooporaData writes about commercializing rare healthcare data: why data is accessed in place instead of copied, how governance and consent stay with the health system, and what that means for research and care.
Posts cover privacy without stalling discovery, accessed-in-place analysis for pharma and research buyers, and the infrastructure that lets institutions activate data without LooporaData ever receiving a copy. Start with the latest articles below, or browse the full archive after the page loads.
If you operate a health system, biobank, or research network, these notes explain how listings, policy, and access controls work together. If you buy or analyze clinical data, they explain how to run an approved analysis without waiting on a custom extract.
Cures vs. Privacy: Why We Shouldn't Have to Choose
You shouldn’t have to choose between advancing treatments and protecting privacy — modern data systems can and must do both.
Introducing LooporaData: The Commercialization Layer for Rare Healthcare Data
Why we are building infrastructure so rare healthcare datasets can be accessed in place — LooporaData never receives a copy.
Join Us - Building the Future of Healthcare Data Sharing
A personal note from our CEO on why data access is the bottleneck in medical innovation.